D. Jelovac

Oncology · 2011

A researcher in the Science corpus: 1 paper; trusts 1 researcher and is trusted by 0 researchers here, as inferred from the citation graph.

Subfields

Whom D. Jelovac trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. Alan Ashworth

Papers from D. Jelovac's perspective

Ordered by how strongly the researchers D. Jelovac trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Randomized intergroup trial of cisplatin-paclitaxel versus cisplatin-cyclophosphamide in women with advanced epithelial ovarian cancer: three-year results. (Journal of the National Cancer Institute)
  2. Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis. (Journal of Clinical Oncology)
  3. A synthetic lethal therapeutic approach: poly(ADP) ribose polymerase inhibitors for the treatment of cancers deficient in DNA double-strand break repair. (Journal of Clinical Oncology)
  4. Neoadjuvant chemotherapy or primary surgery in stage IIIC or IV ovarian cancer. (New England Journal of Medicine)
  5. Phase III trial of carboplatin and paclitaxel compared with cisplatin and paclitaxel in patients with optimally resected stage III ovarian cancer: a Gynecologic Oncology Group study. (Journal of Clinical Oncology)
  6. Recurrent epithelial ovarian carcinoma: a randomized phase III study of pegylated liposomal doxorubicin versus topotecan. (Journal of Clinical Oncology)
  7. Review Cancer Susceptibility and the Functions of BRCA1 and BRCA2
  8. Phase II study of bevacizumab in patients with platinum-resistant ovarian cancer or peritoneal serous cancer. (Journal of Clinical Oncology)
  9. Gemcitabine plus carboplatin compared with carboplatin in patients with platinum-sensitive recurrent ovarian cancer: an intergroup trial of the AGO-OVAR, the NCIC CTG, and the EORTC GCG. (Journal of Clinical Oncology)
  10. Grading Ovarian Serous Carcinoma Using a Two-Tier System (American Journal of Surgical Pathology)

Their papers